Angiodynamics to present at the oppenheimer 35th annual healthcare medtech and services virtual conference

Latham, n.y.--(business wire)--angiodynamics, inc. (nasdaq: ango), a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options, and improving quality of life for patients, today announced that jim clemmer, president and chief executive officer, and stephen trowbridge, executive vice president and chief financial officer, will present at the oppenheimer 35th annual healthcare medtech and service.
ANGO Ratings Summary
ANGO Quant Ranking